Customization: | Available |
---|---|
Certification: | ISO, FDA, HACCP |
Assay Method: | HPLC, UV |
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Product Name | Lumbrokinase | CAS | 556743-18-1 |
MF | C12H15N302S | Shelf Life | 24 Months |
Direct dissolution: directly acts on fibrin and fibrinogen to degrade them.
Indirect dissolution: activates the body's plasminogen to convert into plasmin, promotes fibrinolysis; stimulates the production of tissue plasminogen activator (t-PA), and enhances fibrinolysis.
Treatment of cardiovascular and cerebrovascular diseases: reduces fibrinogen content and whole blood viscosity, dissolves blood clots, improves blood fluidity, and is used for coronary heart disease, angina pectoris, cerebral infarction, deep vein thrombosis of lower limbs, etc.
Other effects: has antioxidant and potential anti-cancer activity; can lower blood sugar, blood pressure, and reduce visceral fat; assists in the treatment of diabetes, nephrotic syndrome, etc.; has a protective and repairing effect on nerve cells, can promote the recovery of nerve function; can also inhibit the release of inflammatory mediators and reduce inflammatory reactions.